[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526608":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":37,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Centro di Riferimento Oncologico - Aviano","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Vincenzo Canzonieri, MD,PhD","Centro di Riferimento Oncologico di Aviano (CRO) - IRCCS","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Vincenzo Canzonieri, MD, PhD","CONTACT","0434 659 618","vcanzonieri@cro.it",[20],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS","RECRUITING","Aviano","Pordenone","33081","Italy","IT",{"type":29,"coordinates":30},"Point",[31,32],12.59472,46.07056,{"lat":32,"lon":31},[35],{"name":15,"role":16,"phone":36,"phoneExt":7,"email":18},"0434659618",{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100526608","the-theranostic-value-of-stard3-in-colorectal-cancer-the-star-study-100526608",false,"NCT06136949","The Theranostic Value of STARD3 in Colorectal Cancer: The STAR Study","The Theranostic Value of STARD3 in Colorectal Cancer: The STAR Study: a Monocentric Observational Study","STAR","Inclusion Criteria:\n\n* Histologically confirmed diagnosis of colorectal cancer, independently from diagnosis stage.\n* Age ≥18 years.\n* Signed informed consent form.\n* Availability of tissue and blood samples stored at the Institutional Biobank for research purposes.\n\nExclusion Criteria:\n\n* Patients for which the tumour biobanking process could compromise the diagnostic assessments.\n* Pregnancy or breast-feeding.\n* History of concomitant or previous malignancy in the previous 5 years, except for adequately treated cutaneous squamous cell carcinoma or surgically removed in situ cervical carcinoma.","ALL","18 Years",{"count":50,"type":51},150,"ESTIMATED","OBSERVATIONAL","This study aims at verifying the overexpression of STARD3 in both early and advanced CRC patients derived tissues, to identify the pathways underpinning tumorigenesis and cancer progression in which STARD3 is involved. Moreover its role as a dynamic biomarker of treatment response and its part in treatment sensitivity will be explored.",[55],"Colorectal Cancer","2023-11-16",{"date":58,"type":59},"2023-11-18","ACTUAL",{"date":61,"type":59},"2023-05-22",{"date":63,"type":51},"2032-12-31",{"name":5,"class":6},1]